Horizon 94 Medcomms Ltd 14656482 false 2023-02-12 2024-02-29 2024-02-29 The principal activity of the company is Medical consultancy Digita Accounts Production Advanced 6.30.9574.0 true 14656482 2023-02-12 2024-02-29 14656482 2024-02-29 14656482 core:CurrentFinancialInstruments core:WithinOneYear 2024-02-29 14656482 bus:Micro-entities 2023-02-12 2024-02-29 14656482 bus:AuditExemptWithAccountantsReport 2023-02-12 2024-02-29 14656482 bus:FilletedAccounts 2023-02-12 2024-02-29 14656482 bus:SmallCompaniesRegimeForAccounts 2023-02-12 2024-02-29 14656482 bus:RegisteredOffice 2023-02-12 2024-02-29 14656482 bus:Director1 2023-02-12 2024-02-29 14656482 bus:PrivateLimitedCompanyLtd 2023-02-12 2024-02-29 14656482 countries:EnglandWales 2023-02-12 2024-02-29 iso4217:GBP xbrli:pure

Registration number: 14656482

Horizon 94 Medcomms Ltd

Unaudited Filleted Financial Statements

for the Period from 12 February 2023 to 29 February 2024

 

Horizon 94 Medcomms Ltd

Contents

Balance Sheet

1 to 2

Notes to the Unaudited Financial Statements

1

 

Horizon 94 Medcomms Ltd

(Registration number: 14656482)
Balance Sheet as at 29 February 2024

2024
£

Fixed assets

856

Current assets

45,120

Prepayments and accrued income

561

Creditors: Amounts falling due within one year

(26,550)

Net current assets

19,131

Total assets less current liabilities

19,987

Accruals and deferred income

(850)

 

19,137

Capital and reserves

19,137

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Bridgewater House
Centruy Park
Caspian Road
Altrincham
Cheshire
WA14 5HH

These financial statements were authorised for issue by the director on 13 September 2024.

Basis of preparation

The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.

2

Staff numbers

The average number of persons employed by the company (including the director) during the period, was 1.

For the financial period ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

 

Horizon 94 Medcomms Ltd

(Registration number: 14656482)
Balance Sheet as at 29 February 2024

These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 13 September 2024
 

.........................................
Dr Sara A Shaw
Director